Skip to main content

Published locations for Newly diagnosed mutant-IDH2 AML: Enasidenib + azacitidine fares better than azacitidine in phase 2

Primary tabs

  • View
  • Get Stamp Tags
  • Published Locations

Breadcrumb

  1. Home
  3. Newly diagnosed mutant-IDH2 AML: Enasidenib + azacitidine fares better than azacitidine in phase 2

User login

  • Reset your password
  • /content/newly-diagnosed-mutant-idh2-aml-enasidenib-azacitidine-fares-better-azacitidine-phase-2
  • /hematology-oncology/article/249254/aml/newly-diagnosed-mutant-idh2-aml-enasidenib-azacitidine-fares